Company Overview

SOHM, Inc. (OTC Pink: SHMN) is a healthcare and pharmaceutical company focused on the development, manufacturing, marketing, and distribution of generic pharmaceutical products, nutraceuticals, over-the-counter healthcare products, and private-label wellness solutions. Public disclosures and OTC market filings indicate the company has historically operated in the pharmaceutical and healthcare distribution sectors, with activities spanning product sourcing, contract manufacturing relationships, and branded healthcare products targeted at both domestic and international markets.

The company’s business model has centered on building a portfolio of healthcare products through licensing arrangements, distribution partnerships, and product commercialization initiatives. SOHM has historically emphasized cost-competitive generic products and wellness formulations aimed at pharmacies, healthcare distributors, and consumer health channels. Available public records indicate the company has evolved from a pharmaceutical distribution-oriented enterprise into a broader healthcare products company with interests in nutraceuticals and specialty healthcare offerings. Some operational details and revenue concentration data are limited due to the company’s OTC reporting profile and the absence of extensive recent SEC reporting.

Business Operations

SOHM, Inc. has disclosed operations related to pharmaceutical trading, generic drug commercialization, nutraceutical products, and healthcare distribution. Its business activities have included sourcing pharmaceutical products through manufacturing and supply relationships, marketing healthcare products under proprietary or partner brands, and distributing products through wholesale and retail healthcare channels. Public disclosures reference involvement in private-label manufacturing arrangements and healthcare product commercialization strategies serving both institutional and consumer markets.

The company’s operations appear to include both U.S.-based and international commercial relationships, particularly in sourcing and manufacturing support. Historical filings and company disclosures reference strategic relationships in Asia, including India, for pharmaceutical manufacturing and supply-chain support. Information regarding active large-scale subsidiaries, joint ventures, or material operating divisions is limited in publicly available verified filings. Data regarding current operational scale, manufacturing ownership, and segment-level revenue contribution is inconclusive based on available public sources.

Strategic Position & Investments

SOHM’s strategic direction has historically focused on expanding its healthcare product portfolio through licensing arrangements, distribution agreements, and selective acquisitions or partnerships in pharmaceutical and wellness sectors. Public company communications have referenced efforts to increase exposure to generic pharmaceuticals, nutraceutical products, and healthcare consumer goods, while leveraging lower-cost manufacturing relationships and international sourcing capabilities.

The company has also explored broader healthcare and biotechnology-related opportunities through collaborations and product development initiatives. Historical disclosures reference investments in product branding, distribution expansion, and healthcare commercialization initiatives. However, publicly verifiable information regarding material acquisitions, large-scale capital investments, or controlling interests in major portfolio companies remains limited. Data concerning the current status of several previously announced initiatives is inconclusive based on available public sources and OTC market disclosures.

Geographic Footprint

SOHM, Inc. is headquartered in the United States, with historical operational and sourcing ties extending into Asia, particularly India. Public disclosures indicate the company has pursued international supplier and manufacturing relationships to support pharmaceutical sourcing, product development, and cost-efficient production strategies.

The company’s commercial focus has primarily involved the North American healthcare market, while utilizing international partnerships for supply-chain and manufacturing support. Available public information suggests SOHM has sought broader international business opportunities through distribution and sourcing arrangements, though verified details regarding active operational facilities or significant revenue-generating international subsidiaries are limited.

Leadership & Governance

SOHM, Inc.’s leadership has historically consisted of executives with backgrounds in pharmaceuticals, healthcare distribution, and business development. Public disclosures and OTC filings indicate management has emphasized growth through healthcare product diversification, strategic partnerships, and expansion of distribution capabilities. Due to limited current reporting transparency, some executive role details may vary across public sources.

Key executives identified in public filings and company disclosures include:

• David Aguilar – Chief Executive Officer
• Shailesh Shah – Founder and former executive leadership figure
• Various appointed directors and officers associated with healthcare operations and corporate administration have been referenced in historical OTC disclosures; however, current role continuity is not fully verifiable through consistently updated public filings.

Leadership communications have generally emphasized expanding healthcare product access, leveraging international manufacturing relationships, and pursuing scalable healthcare distribution opportunities. Certain governance and executive structure details are inconclusive based on available public sources.